title: [Persistent influenza virus infection in a patient treated with alemtuzumab].
authors.affiliation: Laboratoire de virologie, hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France.
authors.forename: S
authors.initials: S
authors.lastname: Burrel
authors.forename: S
authors.initials: S
authors.lastname: Dilhuydy
authors.forename: K
authors.initials: K
authors.lastname: Bouabdallah
authors.forename: M-É
authors.initials: MÉ
authors.lastname: Lafon
authors.forename: N
authors.initials: N
authors.lastname: Milpied
authors.forename: H
authors.initials: H
authors.lastname: Fleury
mesh_terms: D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002908:Chronic Disease; D006801:Humans; D053122:Influenza A Virus, H3N2 Subtype; D007251:Influenza, Human / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000150:complications*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab